These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 24649552)

  • 21. [Histological classification and assessment of malignant melanomas].
    Hornstein OP
    Haematol Blood Transfus; 1978; 21():249-75. PubMed ID: 738637
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical aspects and prognosis of malignant melanoma].
    Heite HJ
    Haematol Blood Transfus; 1978; 21():233-47. PubMed ID: 738636
    [No Abstract]   [Full Text] [Related]  

  • 23. [New aspects of immunotherapy of malignant melanoma].
    Enk A
    Praxis (Bern 1994); 2001 Mar; 90(10):403-6. PubMed ID: 11305186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging therapies for melanoma.
    Katipamula R; Markovic SN
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):553-60. PubMed ID: 18402522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Melanoma].
    Saida T
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1386-91. PubMed ID: 17033225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of adult patients with cutaneous melanoma without distant metastasis. 2005 update of the French Standards, Options and Recommendations guidelines. Summary report.
    Saiag P; Bosquet L; Guillot B; Verola O; Avril MF; Bailly C; Cupissol D; Dalac S; Danino A; Dréno B; Grob JJ; Leccia MT; Renaud-Vilmer C; Négrier S;
    Eur J Dermatol; 2007; 17(4):325-31. PubMed ID: 17540641
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunotherapy as an adjuvant therapy in the management of advanced, surgically resected, melanoma.
    Kalani AD; Jack A; Montenegro G; Degliuomini J; Wallack MK
    G Ital Dermatol Venereol; 2008 Feb; 143(1):59-70. PubMed ID: 18833052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognosis and determinants of outcome following locoregional or distant recurrence in patients with cutaneous melanoma.
    Francken AB; Accortt NA; Shaw HM; Wiener M; Soong SJ; Hoekstra HJ; Thompson JF
    Ann Surg Oncol; 2008 May; 15(5):1476-84. PubMed ID: 18196345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melanoma: the management of local recurrence and in-transit metastasis.
    Couture J
    Can J Surg; 1982 Nov; 25(6):698-700. PubMed ID: 7139431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant immunotherapy. Treatment of high risk patients with malignant melanoma.
    Thomas JH; Maloney BE; Jewell WR
    J Kans Med Soc; 1978 Mar; 79(3):107-10. PubMed ID: 632640
    [No Abstract]   [Full Text] [Related]  

  • 31. [Malignant melanoma. Prognostic factors].
    Schnyder UW
    Schweiz Rundsch Med Prax; 1988 Apr; 77(17):453-5. PubMed ID: 3375670
    [No Abstract]   [Full Text] [Related]  

  • 32. [Combined and complex treatment of patients with II-stage malignant skin melanoma using hyperthermia].
    Zhavrid EA; Fradkin SZ; Bezruchko VI; Firmanchuk AV; Proleskovskiĭ AK
    Vopr Onkol; 1986; 32(3):52-7. PubMed ID: 3962258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnosis and treatment of malignant melanoma of the skin (a lecture)].
    Denisov LE; Kurdina MI
    Khirurgiia (Mosk); 1996; (1):17-22. PubMed ID: 8683912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Current aspects in the treatment of malignant melanoma].
    Barth A; Cerny T
    Schweiz Med Wochenschr; 1994 Sep; 124(36):1592-603. PubMed ID: 7939527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between responsiveness of cancer cells to Oncostatin M and/or IL-6 and survival of stage III melanoma patients treated with tumour-infiltrating lymphocytes.
    Lacreusette A; Lartigue A; Nguyen JM; Barbieux I; Pandolfino MC; Paris F; Khammari A; Dréno B; Jacques Y; Blanchard F; Godard A
    J Pathol; 2008 Dec; 216(4):451-9. PubMed ID: 18798220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melanoma: from darkness to promise.
    Gasent Blesa JM; Grande Pulido E; Alberola Candel V; Provencio Pulla M
    Am J Clin Oncol; 2011 Apr; 34(2):179-87. PubMed ID: 20498590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapy for metastatic melanoma: an overview and update.
    Boyle GM
    Expert Rev Anticancer Ther; 2011 May; 11(5):725-37. PubMed ID: 21554048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The treatment of patients with generalized melanoma of the skin].
    Budiak VA; Poluéktov IuA; Kislitsina VS; Soloveĭ PF; Vasilevitskaia AG
    Lik Sprava; 1992 Aug; (8):95-6. PubMed ID: 1475942
    [No Abstract]   [Full Text] [Related]  

  • 39. [Guidelines for clinical practice: Standards, Options and Recommendations 2005 for the management of adult patients exhibiting an M0 cutaneous melanoma, full report. National Federation of Cancer Campaign Centers. French Dermatology Society. Update of the 1995 Consensus Conference and the 1998 Standards, Options, and Recommendations].
    Négrier S; Saiag P; Guillot B; Verola O; Avril MF; Bailly C; Cupissol D; Dalac S; Danino A; Dreno B; Grob JJ; Leccia MT; Renaud-Vilmer C; Bosquet L; ;
    Ann Dermatol Venereol; 2005 Dec; 132(12 Pt 2):10S3-10S85. PubMed ID: 16521904
    [No Abstract]   [Full Text] [Related]  

  • 40. Malignant melanoma.
    Califano J; Nance M
    Facial Plast Surg Clin North Am; 2009 Aug; 17(3):337-48. PubMed ID: 19698915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.